{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:29:19Z","timestamp":1790634559105,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/phm.0b013e31821f6c40","type":"journal-article","created":{"date-parts":[[2011,6,3]],"date-time":"2011-06-03T15:16:02Z","timestamp":1307114162000},"page":"554-563","source":"Crossref","is-referenced-by-count":11,"title":["Treating Spastic Equinus Foot from Cerebral Palsy with Botulinum Toxin Type A: What Factors Influence the Results?"],"prefix":"10.1097","volume":"90","author":[{"given":"Samuel Ignacio","family":"Pascual-Pascual","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Pascual-Castroviejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro J.","family":"Garcia Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210202","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000311391.00944.c4","article-title":"Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review).","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"R2-4-20210202","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1185\/030079904125003962","article-title":"Safety of botulinum toxin type A: A systematic review and meta-analysis.","volume":"20","author":"Naumann","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R3-4-20210202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ejpn.2008.10.006","article-title":"Safety of botulinum toxin type A in children younger than 2 years.","volume":"13","author":"Pascual-Pascual","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"key":"R4-4-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1017\/S001216220700014X.x","article-title":"Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy.","volume":"49","author":"Desloovere","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"R6-4-20210202","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin: Chemistry, pharmacology toxicity and immunology.","volume":"20","author":"Brin","year":"1997","journal-title":"Muscle Nerve"},{"issue":"suppl 4","key":"R7-4-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2006.01648.x","article-title":"The structure and mode of action of different botulinum toxins.","volume":"13","author":"Dolly","year":"2006","journal-title":"Eur J Neurol"},{"key":"R8-4-20210202","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1017\/S0012162201000445","article-title":"Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity.","volume":"43","author":"Bakheit","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"R9-4-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2310\/7010.2001.6901","article-title":"Use of botulinum toxin type A in pediatric patients with cerebral palsy: A three-center retrospective chart review.","volume":"16","author":"Gormley","year":"2001","journal-title":"J Child Neurol"},{"key":"R10-4-20210202","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1469-8749.2004.tb00511.x","article-title":"Botulinum toxin in the management of cerebral palsy.","volume":"46","author":"Jefferson","year":"2004","journal-title":"Dev Med Child Neurol"},{"key":"R11-4-20210202","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1542\/peds.2007-0016","article-title":"Botulinum toxin for spasticity in children with cerebral palsy: A comprehensive evaluation.","volume":"120","author":"Bjornson","year":"2007","journal-title":"Pediatrics"},{"key":"R12-4-20210202","first-page":"S15","article-title":"Botulinum toxin A in the management of children with cerebral palsy: Indications and outcome.","volume":"4","author":"Boyd","year":"1997","journal-title":"Eur J Neurol"},{"key":"R13-4-20210202","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1111\/j.1468-1331.1999.tb00031.x","article-title":"Objective measurement of clinical findings in the use of botulinum toxin type A for the management of children with cerebral palsy.","volume":"6","author":"Boyd","year":"1999","journal-title":"Eur J Neurol"},{"key":"R14-4-20210202","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1067\/mpd.2000.109107","article-title":"Botulinum toxin A in cerebral palsy: Functional outcomes.","volume":"137","author":"Graham","year":"2000","journal-title":"J Pediatr"},{"key":"R15-4-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpn.2006.08.006","article-title":"European consensus Table 2006 on botulinum toxin for children with cerebral palsy.","volume":"10","author":"Heinen","year":"2006","journal-title":"Eur J Paediatr Neurol"},{"key":"R16-4-20210202","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2006.09.010","article-title":"Effect of multilevel botulinum toxin A and comprehensive rehabilitation on gait in cerebral palsy.","volume":"36","author":"Scholtes","year":"2007","journal-title":"Pediatr Neurol"},{"key":"R17-4-20210202","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1469-8749.2007.00781.x","article-title":"A systematic review of the effects of casting on equinus in children with cerebral palsy: An evidence report of the AACPDM.","volume":"49","author":"Blackmore","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"R18-4-20210202","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1097\/01.PHM.0000141131.66648.E9","article-title":"Botulinum toxin A injections in children: Technique and dosing issues.","volume":"83","author":"Kinnett","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"R19-4-20210202","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mus.880160913","article-title":"Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.","volume":"16","author":"Shaari","year":"1993","journal-title":"Muscle Nerve"},{"key":"R20-4-20210202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0012162203000380","article-title":"Effect of muscle activity and botulinum toxin dilution volume on muscle paralysis.","volume":"45","author":"Kim","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"R21-4-20210202","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00002060-200205000-00007","article-title":"Botulinum toxin in upper limb spasticity after acquired brain injury: A randomized trial comparing dilution techniques.","volume":"81","author":"Francisco","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"R22-4-20210202","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/01.PHM.0000137314.38806.95","article-title":"Botulinum toxin for lower limb spasticity in children with cerebral palsy: A single-blinded trial comparing dilution techniques.","volume":"83","author":"Lee","year":"2004","journal-title":"Am J Phys Med Rehabil"},{"key":"R23-4-20210202","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1002\/(SICI)1097-4598(1997)6+<181::AID-MUS13>3.0.CO;2-9","article-title":"Cerebral palsy: A rational approach to a treatment protocol and the role of botulinum toxin in treatment.","volume":"20","author":"Russman","year":"1997","journal-title":"Muscle Nerve"},{"key":"R24-4-20210202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0966-6362(99)00054-5","article-title":"Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.","volume":"11","author":"Graham","year":"2000","journal-title":"Gait Posture"},{"key":"R25-4-20210202","doi-asserted-by":"crossref","first-page":"303","DOI":"10.33588\/rn.4405.2006340","article-title":"Guia terapeutica de la espasticidad infantil con toxina botulinica.","volume":"44","author":"Pascual-Pascual","year":"2007","journal-title":"Rev Neurol"},{"key":"R26-4-20210202","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01241398-199405000-00005","article-title":"Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial.","volume":"14","author":"Koman","year":"1994","journal-title":"J Pediatr Orthop"},{"key":"R27-4-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1468-1331.2000.00043.x","article-title":"Progressive response to botulinum A toxin in cerebral palsy.","volume":"7","author":"Garcia Ruiz","year":"2000","journal-title":"Eur J Neurol"},{"key":"R28-4-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/adc.83.6.481","article-title":"Randomized, double blind, placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.","volume":"83","author":"Ubhi","year":"2000","journal-title":"Arch Dis Child"},{"key":"R29-4-20210202","first-page":"540","article-title":"Preliminary trial of carisoprodol in multiple sclerosis.","volume":"192","author":"Ashworth","year":"1964","journal-title":"Practitioner"},{"key":"R32-4-20210202","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-2007-973475","article-title":"Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: A randomized, double-blind study of 'high-dose' versus 'low-dose' treatment.","volume":"30","author":"Wissel","year":"1999","journal-title":"Neuropediatrics"},{"key":"R33-4-20210202","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1055\/s-2007-964998","article-title":"Treatment of spastic equinus gait with botulinum toxin A: Does dose matter? Analysis of a clinical cohort.","volume":"37","author":"Satila","year":"2006","journal-title":"Neuropediatrics"},{"key":"R34-4-20210202","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1212\/WNL.46.5.1306","article-title":"Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial.","volume":"46","author":"Simpson","year":"1996","journal-title":"Neurology"},{"key":"R35-4-20210202","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1017\/S0012162206000132","article-title":"Clinical assessment of spasticity in children with cerebral palsy: A critical review of available instruments.","volume":"48","author":"Scholtes","year":"2006","journal-title":"Dev Med Child Neurol"},{"key":"R36-4-20210202","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.sc.3101928","article-title":"Spasticity-assessment: A review.","volume":"44","author":"Biering-Sorensen","year":"2006","journal-title":"Spinal Cord"}],"container-title":["American Journal of Physical Medicine &amp; Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PHM.0b013e31821f6c40","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T23:36:15Z","timestamp":1741217775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002060-201107000-00004"}},"subtitle":["An Analysis of 189 Consecutive Cases"],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/phm.0b013e31821f6c40","relation":{},"ISSN":["0894-9115"],"issn-type":[{"value":"0894-9115","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}